Cargando…
LBMON174 Germline Molecular Genetics Of Pituitary Adenomas
INTRODUCTION: Pituitary adenomas (PA) are common. Considered to be mostly sporadic tumors for a long time, it has become clear over the last decade that a significant proportion of PA carry germline and/or somatic mutations. This study investigated the germline genetics of a large series of patients...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625149/ http://dx.doi.org/10.1210/jendso/bvac150.980 |
_version_ | 1784822415154479104 |
---|---|
author | Alzahrani, Ali Nafisah, Abdulghani Bin Alswailem, Meshael Alsaihati, Burair Alnassar, Anhar Bin Afeef, Ahmed AlQuraa, Reem Alsuhaibani, Rawan Alhadlaq, Omar Altwaijry, Yasser A Abothenain, Fayha AlBaz, Batoul Aljafar, Hussein Moria, Yosra Butt, Mohammad Imran Alkabbani, Abdulrahman Ghiatheddin Alshaikh, Omalkhaire M |
author_facet | Alzahrani, Ali Nafisah, Abdulghani Bin Alswailem, Meshael Alsaihati, Burair Alnassar, Anhar Bin Afeef, Ahmed AlQuraa, Reem Alsuhaibani, Rawan Alhadlaq, Omar Altwaijry, Yasser A Abothenain, Fayha AlBaz, Batoul Aljafar, Hussein Moria, Yosra Butt, Mohammad Imran Alkabbani, Abdulrahman Ghiatheddin Alshaikh, Omalkhaire M |
author_sort | Alzahrani, Ali |
collection | PubMed |
description | INTRODUCTION: Pituitary adenomas (PA) are common. Considered to be mostly sporadic tumors for a long time, it has become clear over the last decade that a significant proportion of PA carry germline and/or somatic mutations. This study investigated the germline genetics of a large series of patients (pts) with PA using whole-exome sequencing (WES) and found a high rate of germline mutations in a number of genes including genes that were only known to be somatically mutated in PA. METHODS: After obtaining ethical approval and informed consent, we randomly included 128 pts (65 Females and 63 males, median age 33 years, IQ range 25-44) with PA (34 microadenomas and 94 macroadenomas). The diagnosis includes acromegaly in 16 pts, Cushing disease in 10 pts, prolactinomas in 50 pts, non-functioning PA in 37 pts, TSHoma in 1 pt, and gonadotrophinoma in 14 pts. None of those pts had a family history of PA or known syndromes. We isolated DNA from peripheral blood and performed WES using Illumina platform (Illumina NovaSeq 6000). For bioinformatics analysis, we removed all intronic and ncRNA variants and focused on exonic, exonic-splicing and splicing variants. We applied strict quality filters within the variant calling pipeline to exclude artifacts arising from the DNA sequencing and subsequent steps. We also removed all synonymous variants and variants marked as benign or likely benign by either Clinvar or ACMG Intervar databases. We followed the ACMG criteria in assigning pathogenicity levels to the variants. We focused on genes that were reported before to be involved in the germline, mosaic or somatic genetics of PA (AIP, GNAS, MEN1, DICER1, CDKN1B, PIK3CA, NF1, USP48 and USP8, GPR101, PRKARIA, PRKACB, MAX, CABLES1, SF3B1 and the SDHx group). RESULTS: We found 35 different variants in the PA-associated genes in 60 pts (46.9%). Some of these variants occurred in more than one patient with a total number of occurrences of 80. Most of these variants are mono-allelic (96.25%). These variants were found in the following genes: GNAS (10 variants in 39 pts), AIP (one variant in 1 patient), CDKN1B (2 variants in 2 pts), DICER1 (1 variant in 1 patient), MEN1 (2 variants in 3 pts), NF1 (3 variants in 3 pts), PIK3CA (1 variant in 1 patient), SDHA (3 variants in 3 pts), SDHAF2 (2 variants in 5 pts), SDHB (4 variants in 3 pts), SDHD (3 variants in 3 pts), USP48 (2 variants in 8 pts) and USP8 (1 variant in 1 patient). These variants included missense, non-sense, and small indels. CONCLUSIONS: Germline variants in genes previously reported to be associated with PA are common in apparently sporadic PA occurring in about 47% of cases. For the first time, we report a significant occurrence of germline variants in genes that were previously known to be only somatically mutated (e. g., USP8, USP48, GNAS). Presentation: Monday, June 13, 2022 12:30 p.m. - 2:30 p.m. |
format | Online Article Text |
id | pubmed-9625149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96251492022-11-14 LBMON174 Germline Molecular Genetics Of Pituitary Adenomas Alzahrani, Ali Nafisah, Abdulghani Bin Alswailem, Meshael Alsaihati, Burair Alnassar, Anhar Bin Afeef, Ahmed AlQuraa, Reem Alsuhaibani, Rawan Alhadlaq, Omar Altwaijry, Yasser A Abothenain, Fayha AlBaz, Batoul Aljafar, Hussein Moria, Yosra Butt, Mohammad Imran Alkabbani, Abdulrahman Ghiatheddin Alshaikh, Omalkhaire M J Endocr Soc Neuroendocrinology and Pituitary INTRODUCTION: Pituitary adenomas (PA) are common. Considered to be mostly sporadic tumors for a long time, it has become clear over the last decade that a significant proportion of PA carry germline and/or somatic mutations. This study investigated the germline genetics of a large series of patients (pts) with PA using whole-exome sequencing (WES) and found a high rate of germline mutations in a number of genes including genes that were only known to be somatically mutated in PA. METHODS: After obtaining ethical approval and informed consent, we randomly included 128 pts (65 Females and 63 males, median age 33 years, IQ range 25-44) with PA (34 microadenomas and 94 macroadenomas). The diagnosis includes acromegaly in 16 pts, Cushing disease in 10 pts, prolactinomas in 50 pts, non-functioning PA in 37 pts, TSHoma in 1 pt, and gonadotrophinoma in 14 pts. None of those pts had a family history of PA or known syndromes. We isolated DNA from peripheral blood and performed WES using Illumina platform (Illumina NovaSeq 6000). For bioinformatics analysis, we removed all intronic and ncRNA variants and focused on exonic, exonic-splicing and splicing variants. We applied strict quality filters within the variant calling pipeline to exclude artifacts arising from the DNA sequencing and subsequent steps. We also removed all synonymous variants and variants marked as benign or likely benign by either Clinvar or ACMG Intervar databases. We followed the ACMG criteria in assigning pathogenicity levels to the variants. We focused on genes that were reported before to be involved in the germline, mosaic or somatic genetics of PA (AIP, GNAS, MEN1, DICER1, CDKN1B, PIK3CA, NF1, USP48 and USP8, GPR101, PRKARIA, PRKACB, MAX, CABLES1, SF3B1 and the SDHx group). RESULTS: We found 35 different variants in the PA-associated genes in 60 pts (46.9%). Some of these variants occurred in more than one patient with a total number of occurrences of 80. Most of these variants are mono-allelic (96.25%). These variants were found in the following genes: GNAS (10 variants in 39 pts), AIP (one variant in 1 patient), CDKN1B (2 variants in 2 pts), DICER1 (1 variant in 1 patient), MEN1 (2 variants in 3 pts), NF1 (3 variants in 3 pts), PIK3CA (1 variant in 1 patient), SDHA (3 variants in 3 pts), SDHAF2 (2 variants in 5 pts), SDHB (4 variants in 3 pts), SDHD (3 variants in 3 pts), USP48 (2 variants in 8 pts) and USP8 (1 variant in 1 patient). These variants included missense, non-sense, and small indels. CONCLUSIONS: Germline variants in genes previously reported to be associated with PA are common in apparently sporadic PA occurring in about 47% of cases. For the first time, we report a significant occurrence of germline variants in genes that were previously known to be only somatically mutated (e. g., USP8, USP48, GNAS). Presentation: Monday, June 13, 2022 12:30 p.m. - 2:30 p.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9625149/ http://dx.doi.org/10.1210/jendso/bvac150.980 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Neuroendocrinology and Pituitary Alzahrani, Ali Nafisah, Abdulghani Bin Alswailem, Meshael Alsaihati, Burair Alnassar, Anhar Bin Afeef, Ahmed AlQuraa, Reem Alsuhaibani, Rawan Alhadlaq, Omar Altwaijry, Yasser A Abothenain, Fayha AlBaz, Batoul Aljafar, Hussein Moria, Yosra Butt, Mohammad Imran Alkabbani, Abdulrahman Ghiatheddin Alshaikh, Omalkhaire M LBMON174 Germline Molecular Genetics Of Pituitary Adenomas |
title | LBMON174 Germline Molecular Genetics Of Pituitary Adenomas |
title_full | LBMON174 Germline Molecular Genetics Of Pituitary Adenomas |
title_fullStr | LBMON174 Germline Molecular Genetics Of Pituitary Adenomas |
title_full_unstemmed | LBMON174 Germline Molecular Genetics Of Pituitary Adenomas |
title_short | LBMON174 Germline Molecular Genetics Of Pituitary Adenomas |
title_sort | lbmon174 germline molecular genetics of pituitary adenomas |
topic | Neuroendocrinology and Pituitary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625149/ http://dx.doi.org/10.1210/jendso/bvac150.980 |
work_keys_str_mv | AT alzahraniali lbmon174germlinemoleculargeneticsofpituitaryadenomas AT nafisahabdulghanibin lbmon174germlinemoleculargeneticsofpituitaryadenomas AT alswailemmeshael lbmon174germlinemoleculargeneticsofpituitaryadenomas AT alsaihatiburair lbmon174germlinemoleculargeneticsofpituitaryadenomas AT alnassaranhar lbmon174germlinemoleculargeneticsofpituitaryadenomas AT binafeefahmed lbmon174germlinemoleculargeneticsofpituitaryadenomas AT alquraareem lbmon174germlinemoleculargeneticsofpituitaryadenomas AT alsuhaibanirawan lbmon174germlinemoleculargeneticsofpituitaryadenomas AT alhadlaqomar lbmon174germlinemoleculargeneticsofpituitaryadenomas AT altwaijryyassera lbmon174germlinemoleculargeneticsofpituitaryadenomas AT abothenainfayha lbmon174germlinemoleculargeneticsofpituitaryadenomas AT albazbatoul lbmon174germlinemoleculargeneticsofpituitaryadenomas AT aljafarhussein lbmon174germlinemoleculargeneticsofpituitaryadenomas AT moriayosra lbmon174germlinemoleculargeneticsofpituitaryadenomas AT buttmohammadimran lbmon174germlinemoleculargeneticsofpituitaryadenomas AT alkabbaniabdulrahmanghiatheddin lbmon174germlinemoleculargeneticsofpituitaryadenomas AT alshaikhomalkhairem lbmon174germlinemoleculargeneticsofpituitaryadenomas |